泡泡玛特，逆市大涨！医药巨头，突传利好

中国基金报01-20

【导读】“股份回购+大摩唱多”，泡泡玛特逆市大涨超9%！恒瑞医药新药临床试验获批中国基金报记者郭玟君1月20日，港股延续调整态势，恒生指数收盘跌0.29%，报26487.51点；恒生科技指数跌1.16%，报5683.44点；恒生中国企业指数跌0.43%，报9094.76点。大市全日成交2377.7亿港元，高于上一交易日的2256.9亿港元。恒生指数成份股中44只上涨，41只下跌，其中，药明康德跌...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2604659192?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-01-20 18:53","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2604659192","market":"hk","top_or_hot":-1,"title":"泡泡玛特，逆市大涨！医药巨头，突传利好","media":"中国基金报","content":"<div>\n<p>【导读】“股份回购+大摩唱多”，泡泡玛特逆市大涨超9%！恒瑞医药新药临床试验获批中国基金报记者 郭玟君1月20日，港股延续调整态势，恒生指数收盘跌0.29%，报26487.51点；恒生科技指数跌1.16%，报5683.44点；恒生中国企业指数跌0.43%，报9094.76点。大市全日成交2377.7亿港元，高于上一交易日的2256.9亿港元。恒生指数成份股中44只上涨，41只下跌，其中，药明康德跌...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120190121a440c16a&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>泡泡玛特，逆市大涨！医药巨头，突传利好</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n泡泡玛特，逆市大涨！医药巨头，突传利好\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-20 18:53 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120190121a440c16a&s=b><strong>中国基金报</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>【导读】“股份回购+大摩唱多”，泡泡玛特逆市大涨超9%！恒瑞医药新药临床试验获批中国基金报记者 郭玟君1月20日，港股延续调整态势，恒生指数收盘跌0.29%，报26487.51点；恒生科技指数跌1.16%，报5683.44点；恒生中国企业指数跌0.43%，报9094.76点。大市全日成交2377.7亿港元，高于上一交易日的2256.9亿港元。恒生指数成份股中44只上涨，41只下跌，其中，药明康德跌...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120190121a440c16a&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SG9999002950.SGD","symbol_name":"United Asian Growth Opportunities SGD","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120190121a440c16a&s=b","article_id":"2604659192","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120190121a440c16a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2604659192","pubTimestamp":1768906407,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"涨幅方面，泡泡玛特涨9.07%，中国人寿涨4.31%，华润置地涨3.71%，领涨蓝筹。“股份回购+大摩唱多”泡泡玛特逆市大涨超9%！1月19日，泡泡玛特披露，当天通过香港联交所购回140万股普通股，每股购回价介于177.7港元至181.2港元，涉及金额达2.51亿港元。泡泡玛特公告称，公司董事会于2025年5月27日审议通过，授权公司进行总数为1.34亿股公司股份回购。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600276":"恒瑞医药","SG9999002950.SGD":"United Asian Growth Opportunities SGD","LU0359201612.USD":"贝莱德中国基金A2","LU0359202008.SGD":"Blackrock China Fund A2 SGD-H","IE0034224299.USD":"PINEBRIDGE ASIA EX JAPAN EQUITY \"A\" (USD) ACC","PMRTY":"Pop Mart International Group Limited","LU1770036033.HKD":"NINETY ONE GSF ASIAN EQUITY \"A\" (HKD) ACC","BK1224":"专卖店","BK1574":"生物医药B类股","LU1481107354.HKD":"HSBC GIF HONG KONG EQUITY \"AD\" (HKD) INC","LU0572944931.SGD":"Janus Henderson Horizon China Opportunities A2 SGD","01276":"恒瑞医药","LU2543165471.USD":"E FUND (HK) GLOBAL QUALITY GROWTH \"A\" (USD) ACC","SG9999001069.SGD":"UOB UNITED ASIA PACIFIC GROWTH (SGD) ACC","SGXZ86797644.SGD":"MAYBANK ASIAN GROWTH AND INCOME-I \"A\" (SGDHDG) INC","LU0531971595.HKD":"HSBC GIF CHINESE EQUITY \"AD\" (HKD) INC","LU0871576103.HKD":"HSBC GIF CHINESE EQUITY \"AC\" (HKD) ACC","SGXZ62798434.SGD":"MAYBANK ASIAN GROWTH AND INCOME-I \"A\" (SGDHDG) ACC","LU0164865239.USD":"HSBC GIF CHINESE EQUITY \"AC\" (USD) ACC","LU0611395673.USD":"NINETY ONE GSF EMERGING MARKETS EQUITY \"A\" (USD) ACC","LU0499858438.USD":"NINETY ONE GSF ASIA PACIFIC EQUITY OPPORTUNITIES \"A\" (USD) INC","LU0327786744.USD":"Janus Henderson Horizon China Opportunities A2 USD","LU0345776255.USD":"NINETY ONE GSF ASIAN EQUITY \"A\" (USD) INC","LU0039217434.USD":"HSBC GIF CHINESE EQUITY \"AD\" INC","LU0359201885.HKD":"BGF CHINA \"A2\" (HKD) ACC","LU0348766576.USD":"ALLIANZ LITTLE DRAGONS \"A\" (USD) INC","BK1161":"生物科技","LU0211977185.USD":"EASTSPRING INVESTMENTS GREATER CHINA EQUITY \"A\" ACC","LU0345775950.USD":"NINETY ONE GSF ASIAN EQUITY \"A\" (USD) ACC","LU0231483743.USD":"abrdn SICAV I - ALL CHINA SUSTAINABLE EQUITY \"A\" (USD) ACC","LU0348767384.USD":"ALLIANZLITTLE DRAGONS \"A\" (USD) ACC","LU0307460666.USD":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC","LU0823426480.USD":"法巴中国股票经典Dis","LU0149721374.USD":"HSBC GIF HONG KONG EQUITY \"AD\" INC","LU1023057109.AUD":"BGF CHINA \"A2\" (AUDHDG) ACC","09992":"泡泡玛特","LU0588546209.SGD":"Eastspring Investments - China Equity Fund AS SGD","LU0593848301.USD":"未来资产亚洲卓越消费股票基金A","LU0823426308.USD":"法巴中国股票基金","BK1515":"抗疫概念","LU0164880469.USD":"HSBC GIF HONG KONG EQUITY \"AC\" ACC","LU0499858602.USD":"NINETY ONE GSF ASIA PACIFIC EQUITY OPPORTUNITIES \"A\" (USD) ACC"},"translate_title":"Pop Mart, bucked the market and rose sharply! Pharmaceutical giants, sudden good news","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600276":1.93,"PMRTY":1.96,"09992":1.96,"01276":1.93},"content_text":"【导读】“股份回购+大摩唱多”，泡泡玛特逆市大涨超9%！恒瑞医药新药临床试验获批中国基金报记者 郭玟君1月20日，港股延续调整态势，恒生指数收盘跌0.29%，报26487.51点；恒生科技指数跌1.16%，报5683.44点；恒生中国企业指数跌0.43%，报9094.76点。大市全日成交2377.7亿港元，高于上一交易日的2256.9亿港元。恒生指数成份股中44只上涨，41只下跌，其中，药明康德跌4.13%，比亚迪股份跌3.67%，舜宇光学科技跌3.25%。涨幅方面，泡泡玛特涨9.07%，中国人寿涨4.31%，华润置地涨3.71%，领涨蓝筹。成交额突出个股方面，腾讯控股成交额达146.38亿港元，跌1.48%；阿里巴巴成交额为88.68亿港元，跌0.44%；小米集团成交额为80.45亿港元，跌2.74%，公司于1月19日回购400万股，回购金额1.46亿港元，但整体市场流动性紧张拖累股价表现。港股其他涨跌幅较大个股有：易通讯集团涨112.3%，获折让约15.08%提现金要约，控股权易主，成交额达842.73万港元；CMON涨30.2%，公司拟按每股0.80港元配售最多1032万股股份，配售价较1月19日收盘价折让约16.67%，所得款项净额约为790万港元，拟用作一般营运资金。香港恒生行业指数中，领涨行业为地产建筑业，涨1.05%，原材料业涨0.82%，必需性消费行业涨0.82%；跌幅方面，信息科技业跌1.72%，医疗保健业跌0.78%，能源业跌0.57%。“股份回购+大摩唱多”泡泡玛特逆市大涨超9%！泡泡玛特放量大涨，最大涨幅达10.40%，全天收于197.20港元/股，大涨9.07%，领涨蓝筹；成交额达58.79亿港元，在恒生指数成份股中排名第四。上涨主要由于公司1月19日斥资2.51亿港元回购股份，以及摩根士丹利发布研报唱多。1月19日，泡泡玛特披露，当天通过香港联交所购回140万股普通股，每股购回价介于177.7港元至181.2港元，涉及金额达2.51亿港元。所有购回股份拟予注销。泡泡玛特公告称，公司董事会于2025年5月27日审议通过，授权公司进行总数为1.34亿股公司股份回购。此次购回的140万股，占授权通过日已发行股份（不含库存股份）的0.1042%。根据规则，公司自本次购回后至2026年2月18日止的30天内，不得发行新股或出售/转让库存股份，除非获交易所批准。摩根士丹利发布研报称，上次回购发生在2024年2月，正值业绩公布前。摩根士丹利预计，泡泡玛特2025年净利润为人民币126亿元，并于2025年底持有200亿元净现金，显示公司具备充裕的财务资源，可进一步回馈股东。恒瑞医药新药临床试验获批1月20日收市后，恒瑞医药发布公告称，HRS-2141片获临床试验批准。公告称，恒瑞医药子公司山东盛迪医药有限公司收到国家药监局核准签发的HRS-2141片（Ⅰ）、（Ⅱ）《药物临床试验批准通知书》，同意开展2型糖尿病适应症的临床试验。该药物为片剂，受理号分别为CXHL2501153和CXHL2501154，审批依据为《中华人民共和国药品管理法》，批准日期为2025年10月21日，经受理后审查通过。公告显示，HRS-2141片（Ⅰ）、（Ⅱ）为固定剂量复方制剂，通过药理机制互补协同降血糖，目前国内外尚无同类药物获批上市。截至公告披露日，该项目累计研发投入约540万元（未经审计），处于临床试验前期阶段，即将启动临床研究。公司同时作出风险提示：药物在获得临床试验批准后，仍需完成全部临床试验并经国家药监局审评审批方可上市。药品研发周期长、环节多，受技术、政策、市场等多重不确定因素影响，存在研发失败或延期风险。公司将依法依规推进项目，并及时披露后续进展。1月20日，恒瑞医药开盘后震荡下行，最终收于全日最低价73.55港元/股，下跌4.36%。编辑：杜妍校对：乔伊制作：舰长审核：陈思扬","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2604659192","isCrawlerRequest":true}